Translating Knowledge Into Practice in Hemorrhagic Stroke - The Cutting Edge of ICH Care

According to the Centers for Disease Control and Prevention (CDC), more than 795,000 people have a stroke each year in the United States. Every 4 minutes, an individual dies from a stroke. The financial impact of strokes on the healthcare system is staggering, with an estimated $34 billion spent annually in the US, which includes the cost of healthcare services, medicines to treat stroke patients, and lost productivity. Although hemorrhagic strokes comprise only 13% of all strokes, they are particularly costly from both a clinical and financial perspective.

Oral anticoagulants increase a patient’s risk of major bleeding events, especially intracerebral hemorrhages. In anticoagulated patients, distinguishing major from minor bleeding and appropriately employing emergent options to manage major bleeding are imperative. Clinicians must be familiar with the risks associated with anticoagulant use, as well as the management approaches to patients with oral anticoagulant-associated intracerebral hemorrhage. Nationally recognized guidelines have provided direction on how to utilize repletion and reversal strategies to manage these types of major bleeding events. 
Educational resources presented by experts from Comprehensive & Primary Stroke Centers and Level 1 Emergency Departments can provide additional guidance for healthcare professionals regarding the presentation and pathophysiology of different types of strokes, the most effective use of imaging modalities for evaluating patients with stroke, and management approaches to patients with stroke, particularly those with oral anticoagulant-associated hemorrhagic stroke.
This program discusses:
•The approach to patients with critical site (intraocular, instraspinal, and intracranial) hemorrhage
•The clinical assessment and imaging evaluation of patients with hemorrhagic stroke, including the identification of which patients with hemorrhagic stroke are more likely to have underlying vascular lesions and which ones are at higher risk of hematoma expansion
•The emergency management of patients with hemorrhagic stroke, including management strategies for preventing hematoma expansion
•Repletion and reversal strategies for the management of hemorrhagic stroke in the anticoagulated patient
•New developments in imaging of patients with hemorrhagic stroke 

Episodes in this Program

• Assessing the Critical Hemorrhage Patient – Intracranial, Intraspinal, and Intraocular Bleeding in the ED 07:05 
• When To Consider Immediate Transfer of a Patient Without Intervention: Are There Times When No Reversal Is Better Than Some Reversal? 08:15 
• Standardizing the Diagnostic Workup for Hemorrhagic Strokes – What Is Left To Do? 11:35 
• What Resources Are Necessary To Optimize Care For the Anticoagulated Hemorrhagic Stroke Patient? 05:56 
• The Future of Imaging in ICH: What is Next? 08:17 
• Case Review: Imaging Strategies and Interpretation in Hemorrhagic Stroke – What Does Every Provider Need To Know?  05:37 
• Prevention of Rebleeding in ICH – What Goes Right, What Goes Wrong: Comparing Two Cases 08:37 
  
  Release Date: 05/27/2022
  Expiration Date: 05/27/2023
  Estimated time to complete activity: 1 hour

To register and review this enduring material, please go to:  https://www.mededonthego.com/Video/program/796

This activity is FREE to all participants.  

1. Describe and define hemorrhagic strokes, their pathophysiology, and imaging techniques used to make an accurate and timely diagnosis
2. Explain the repletion and reversal strategies required to manage hemorrhagic stroke
3. Examine different imaging techniques to delineate the type of bleeding

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati Office of Continuing Medical Education, EMCREG-International and TotalCME, Inc. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Continuing Nurse Education
Approved contact hours: 1.0 total continuing education contact hours for nurses are approved by the Ohio Board of Nursing through the OBN Approver Unit at the University of Cincinnati College of Nursing, Continuing Education Program (OBN-011-93). Contact hours are valid in most states. Program: #220107.

Continuing Pharmacy Education
The University of Cincinnati James L. Winkle College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0050-9999-21-086-H01-P. This activity is worth a total of 1.0 CEUs (0.1 contact hours). 

Note: Pharmacists must complete all episodes in this activity to claim credit.

Please contact the James L. Winkle College of Pharmacy Continuing Pharmacy Education Office at 513-558-4716 or [email protected] with questions or concerns.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This activity is supported in part by an independent educational grant from Alexion Pharmaceuticals, Inc.